Instrument overview

VXRTVaxart Inc

StockOTC美國Health careEU retail: available

−6.8% today · +13.9% over a year

No score: too little data.

No dividend.

Not scored: not enough data for a fair comparison.

Red flags and notes

  • Caution. Negative free cash flow in at least two of the last three years. More in the glossary → Negative free cash flow in at least two of the last three years.
  • Below $1 Price below one US dollar: not ranked against peers.

Price chart

Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.

Key metrics

Valuation

P/E
2.6
P/B
1.2
P/S
0.4
EV/EBIT
0.9
Free-cash-flow yield
33.5%
Market cap (EUR)
€89M

Profitability and debt

Return on equity
67.0%
Return on invested capital
177.3%
Net debt / EBITDA
−1.40

Dividends

Dividend yield
0.00%
Payout ratio
0%
Years of dividend growth
0

Returns and risk

1 day
−6.8%
1 month
−14.6%
1 year
+13.9%
Volatility, 1 yr
89.3%
Max drawdown, 1 yr
−48.8%
Beta
1.34

Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.

News and filings

What the marks mean
  • FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
  • Media reportA headline from a named media outlet. We link to it and do not check it.
  • RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.

Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.

Score changes in the last 12 months

Every published rating and change, logged when it was published (EU Market Abuse Regulation).

Show the log: 1 entries
DateEventBalancedGrowth · IncomeWarningsPrice at publication
First rating —/10 — · — Available with Invest Pro

Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.